141 related articles for article (PubMed ID: 10331044)
1. Plasma endothelin in cyclosporine A-treated renal transplant patients.
Grekas D; Bamichas G; Karamouzis M; Bacharaki D; Savidis N; Tourkantonis A
Transplant Proc; 1999 May; 31(3):1703-5. PubMed ID: 10331044
[No Abstract] [Full Text] [Related]
2. Endothelin-1 plasma levels in cyclosporine-treated stable renal transplant patients.
Costa C; Cauduro RL; Lhulier F; Cabral RD; Garcia RG; Manfro RC
Transplant Proc; 2002 Mar; 34(2):487-8. PubMed ID: 12009599
[No Abstract] [Full Text] [Related]
3. Cyclosporine therapy in pancreas transplantation.
Davidson I; Lu C; Melone D; Risser R
Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
[No Abstract] [Full Text] [Related]
4. A retrospective analysis of Neoral C2 monitoring in Chinese renal transplantation recipients.
Tan J; Tang X
Transplant Proc; 2003 Feb; 35(1):232-3. PubMed ID: 12591377
[No Abstract] [Full Text] [Related]
5. Conventional versus Neoral cyclosporine in renal transplantation.
Rovelli E; Bucci A; Maldifassi P; Belfiore A; D'Amico G
Transplant Proc; 1998 Aug; 30(5):1764-5. PubMed ID: 9723272
[No Abstract] [Full Text] [Related]
6. Induction therapy with bolus ATG increases cyclosporine sensitivity in renal transplant recipients.
Varghese Z; Abudher MN; Fernando ON; Moorhead JF
Transplant Proc; 2001 May; 33(3):2251-3. PubMed ID: 11377518
[No Abstract] [Full Text] [Related]
7. Clinical study of sandimmun neoral in cadaveric renal transplantation.
Xue W; Chen Y; Xing J; Tian P
Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
[No Abstract] [Full Text] [Related]
8. Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
Griffin PJ; Moore RH; Jurewicz WA; Lord RH; Webley Y; Jenkins J
Transplant Proc; 1997; 29(1-2):303. PubMed ID: 9123007
[No Abstract] [Full Text] [Related]
9. Effect of grapefruit juice on serum concentration of cyclosporine in Iranian renal transplant patients.
Mehrsai AR; Pourmand G; Mansour D; Zand S; Rezaali A
Transplant Proc; 2003 Nov; 35(7):2739-41. PubMed ID: 14612100
[No Abstract] [Full Text] [Related]
10. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a novel cyclosporine formulation, using a dose-normalized equivalence method.
First MR; Weiskittel P; Burton M; Shah M; Dreyer D; Fleck P; Bey C; Peddi R; Canafax D; Schroeder TJ
Transplant Proc; 1998 Aug; 30(5):1701-5. PubMed ID: 9723249
[No Abstract] [Full Text] [Related]
11. Treatment with high-dose folic acid effectively lowers plasma homocysteine concentration in cyclosporine-treated renal transplant recipients.
Arnadottir M; Hultberg B
Transplantation; 1997 Oct; 64(7):1087. PubMed ID: 9381536
[No Abstract] [Full Text] [Related]
12. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
Guan D; Wang R; Lu J; Wang M; Xu C
Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
[No Abstract] [Full Text] [Related]
13. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
Sharma DR; Singh S
J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
[TBL] [Abstract][Full Text] [Related]
14. Optimization of cyclosporine exposure utilizing C(2) level monitoring in de novo renal transplant recipients: the Toronto General Hospital experience.
Maham N; Cardella C; Cattran D; Fenton S; O'Grady C; Hamill J; Smith R; Cole E
Transplant Proc; 2001; 33(7-8):3098-9. PubMed ID: 11750331
[No Abstract] [Full Text] [Related]
15. Gene expression of the renal endothelin system in renal transplant recipients on cyclosporine A based immunosuppression.
Asberg A; Attramadal H; Midtvedt K; Sund S; Hartmann A; Berg KJ
Transplantation; 1999 Apr; 67(7):1056-60. PubMed ID: 10221493
[TBL] [Abstract][Full Text] [Related]
16. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
Rial MC; Frias S; Argento J; Tessler J; Casadei D
Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
[No Abstract] [Full Text] [Related]
17. Polyclonal/monoclonal ratio in kidney and bone marrow transplanted patients treated with cyclosporine.
Capone D; De Marino V; Caso N; Stanziale P; Fontana R; Imperatore P; De Marino V; Pisanti N
Clin Transplant; 1998 Oct; 12(5):430-3. PubMed ID: 9787953
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine does not influence serum cholesterol in kidney transplant recipients.
Matzkies FK; Keuthage W; Kobelt V; Hillebrand U; Gerhardt U; Suwelack B; Hohage H
Transplant Proc; 2002 Aug; 34(5):1795-6. PubMed ID: 12176580
[No Abstract] [Full Text] [Related]
19. Conversion to cyclosporine microemulsion (Neoral) in stable renal transplant patients: results from a single center.
Cossu M; Satta R; Branca GF; Pala PG; Serra G; Satta RP; Sorba G
Transplant Proc; 1998 Aug; 30(5):1762-3. PubMed ID: 9723271
[No Abstract] [Full Text] [Related]
20. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
De Palma MT; Giordano M; Colella V; Palumbo F; De Nicolo VE; Caringella DA
Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
